Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer. Minne RL, Luo NY, Traynor AM, Huang M, et al. Clin Lung Cancer 2024 May 10:S1525-7304(24)00080.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Minne RL, Luo NY, Traynor AM, Huang M, et al. Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer. Clin Lung Cancer 2024 May 10:S1525-7304(24)00080.
PMID: 38852006